http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110893240-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110893240-B |
| titleOfInvention | Application of NME2 gene in inhibiting avian reovirus replication |
| abstract | The invention discloses application of an avian NME2 gene in inhibiting replication of avian reoviruses. The invention provides an application of NME2 gene or related biological materials thereof in preparing products for inhibiting the replication of avian reoviruses; the related biological material is an expression cassette containing the NME2 gene, a recombinant vector, a recombinant bacterium or a transgenic cell line or protein encoded by the NME2 gene. Experiments prove that the overexpression of the NME2 gene in DF1 cells and fluorescent quantitative PCR detection prove that the overexpression of the NME2 gene can inhibit the replication of ARV infection. The invention provides a new thought for preparing the biological preparation for clinically treating the ARV infection, and has important significance for the clinical treatment of the ARV. |
| priorityDate | 2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 300.